Best White Label Telehealth Platforms for Your Brand

What should the word platform mean for your business?

White label describes the patient-facing brand relationship; it does not, by itself, establish who supplies clinicians, dispenses medication or runs administrative support. Two vendors can both offer a branded portal while expecting very different work from your team. The first buying decision is therefore about the operation behind the interface.

Use the white-label telehealth guide to separate the layers: marketing and acquisition, intake and commerce, independent clinical care, pharmacy or laboratory services, and ongoing administration. Decide which layers you already have and which you need the platform arrangement to supply.

This list does not rank medical quality or claim independently measured outcomes. It identifies relevant operating models and documented differences. Vendor claims are dated as of October 22, 2026. A field that is not stated publicly should become a procurement question, not a negative capability score.

Which options are worth evaluating?

When should TEHR be on your shortlist?

TEHR is an option for brands that want white-label technology and administrative infrastructure connected to an independent licensed clinical network with 50-state reach, subject to program, state and patient eligibility. It supports clinician e-prescribing, pharmacy coordination, AI-assisted intake, payments and subscriptions. Independent licensed providers retain clinical decisions.

Its operators built DudeMeds, Peptiders, TellyMeds and FansMeds and migrated thousands of their own patients. That background is useful when discussing recurring orders, support handoffs and a real transition. It should lead to a specific implementation plan rather than an automatic claim that every brand can migrate on the same schedule.

Trade-off: Obtain the exact clinical, pharmacy, integration and support scope in writing. TEHR states a flat platform subscription plus flat transaction fee and 0% revenue share; contact TEHR for a scoped quote. Its selected peptide programs are pending and are not open for prescribing or fulfillment. See the platform scope before treating any proposal as all-inclusive.

When should you evaluate OpenLoop?

Strength: OpenLoop’s Launchpad describes a no-code website, branded portal, intake, clinicians and operating workflows. The current product is broader than a clinician network; its official page also describes integration into existing customer systems. Official launchpad and platform.

Evaluate OpenLoop when the brand needs a broader operating package rather than only a clinical connection. The important comparison is how the proposed platform handles your program and the work your team retains. Ask to see a continuing patient, a fulfillment exception and an administrative escalation rather than only a storefront build.

Trade-off: The reviewed page does not establish a universal numeric rate card or revenue-share policy. Request itemized terms and identify the work your team retains. Treat its fastest launch statement as a vendor estimate with readiness conditions, not a migration guarantee.

When should you evaluate Wheel?

Strength: Wheel’s Horizon offering combines a configurable platform, clinician network and clinical operations. Its launch page describes an EMR, branded patient experience and modular programs; connected services include prescription fulfillment, pharmacy delivery and laboratory connections. Official launch virtual care; Connected services.

Evaluate Wheel when configured care programs and a particular distribution channel are central to the business. Compare the patient experience and reporting for that channel, not an abstract feature count. A consumer subscription operation and an existing care organization can need different commercial workflows despite sharing a clinical category.

Trade-off: The reviewed public pages do not establish universal numeric pricing or revenue-share terms. Ask how the exact channel, program, patient experience and service connections are packaged. A connection to a service does not necessarily include the cost of using that service.

When should you evaluate Beluga Health?

Strength: Beluga offers direct API, hosted intake and platform-partner configurations. Its pricing page explicitly describes no cut of customer revenue, flat monthly access, per-visit fees and pharmacy/lab pass-through with disclosed service charges. Dollar amounts are quoted during scoping. Official platform integration paths; Pricing.

Evaluate Beluga when the brand has commerce or product capabilities it wants to retain. Its modular routes make the boundary between clinical infrastructure and customer-facing software especially important. Name the owner of every handoff, including support questions that cross from an administrative issue into a clinical concern.

Trade-off: Determine which company supplies commerce, subscriptions and patient support in your chosen configuration. A clinical backend can be the right fit for an existing stack, but its fee alone should not be compared with the price of a complete commercial operation.

When should you evaluate Cuvo Health?

Strength: Cuvo’s pricing page publishes platform plans and a completed-consult charge, explicitly states no revenue share or added platform transaction fee, and describes patient/data migration without an additional migration charge. It also distinguishes full-platform plans from its existing-stack Prescribe option. Official pricing.

Evaluate Cuvo when public commercial structure and an explicit migration offer help procurement. Compare the package suited to your actual starting point, including any existing-stack option. Published terms make a discussion more concrete, but your proposal still needs to identify clinical services, payment costs and the work included in migration.

Trade-off: Include setup, recurring and clinical charges in the comparison; standard payment-processing and other delivery costs still matter. A clinical connection to an existing stack has different dependencies from building a full brand. Confirm what its migration offer covers for your actual records.

When should you evaluate Bask Health?

Strength: Bask’s plans page describes storefront, patient portal, EMR/e-prescribing, provider access and pharmacy fulfillment. Its current Core/Growth/Enterprise labels differ from a July 31, 2026 article describing Mini/Growth/Enterprise, so the public packaging should be reconciled before buying. Official plans and pricing; Plan comparison, July 31, 2026.

Evaluate Bask when your team wants to configure DTC workflows and manage the corresponding operating responsibilities. Ask for the current plan rather than relying on a combination of old and new public materials. Confirm who maintains configuration and who resolves an exception once the software has identified it.

Trade-off: Obtain the current written rate card instead of combining features and prices from conflicting pages. Confirm plan-specific access to integrations and support. Its documented clinical and pharmacy connections mean it should not be described as merely a storefront builder.

When should you evaluate Telegra?

Strength: Telegra describes intake, commerce, pharmacy routing, a branded portal/app and APIs. Its public migration documentation covers CSV imports for patients, products, coupons, orders and subscriptions, with dry-run validation before production import. This is documented import capability, not proof of every outbound export option. Official platform overview; CSV migration.

Evaluate Telegra when commerce and a consistent branded patient experience are key requirements. Its documentation provides concrete migration-import questions, but clinical history and payment arrangements need separate assessment. Confirm which patient surfaces are included in the proposed plan and how continuing customers will access their next action.

Trade-off: Request recurring costs separately from published onboarding fees and confirm plan-specific app and pharmacy options. Its conditions page marks peptides Coming Soon; that is not a currently available prescribing or fulfillment program. Conditions and program status.

When should you evaluate Lithos Health?

Strength: Lithos describes a white-label medical practice delivered through an API while customers build their own product. Its pricing page publishes per-completed-visit bands, and its migration page describes staged transitions with parallel testing and clinical continuity work. Official practice infrastructure; Pricing.

Evaluate Lithos when the business wants to own its product experience and use a clinical practice API behind it. That can fit a capable engineering team, but it is not equivalent to buying a finished storefront operation. Include development and administrative work when comparing the total cost of this architecture.

Trade-off: The brand must account for building and operating the customer-facing product. Compare the appropriate modality and graduated volume bands, not only the lowest advertised visit rate. Public migration guidance is useful, but your source records and program still determine the plan. Migration.

How should you test the proposed operating model?

Test brand control at the places patients actually encounter it: intake, checkout, scheduling, messages, portal, shipment communication and ongoing billing. Ask what can be configured and what is fixed. Required medical-practice and pharmacy identification should remain visible where appropriate; a coherent brand experience does not mean concealing the entities delivering care.

Then test operating control. Can the right team see a stalled journey and resolve it? Does a clinical change reach the commercial system without an unsafe assumption? Can your staff distinguish a payment issue from a medical question? The answers should be demonstrated with a realistic workflow and reflected in the written service scope.

Do not allow a broad white-label claim to substitute for data and exit terms. Confirm access to patient and commercial records, lawful transfer procedures and the practical steps required if you later change arrangements. That conversation is easiest before the platform becomes central to your operation.

How should you compare the complete cost?

Normalize the proposals around the same service mix and volume. Separate setup, platform access, clinical activity, medication, laboratory services, shipping, payment processing, support and work retained internally. Ask how cancellations, refunds, failed payments and changed treatment plans affect charges.

A no-revenue-share model is useful to understand, but it is not unique to TEHR and does not by itself establish the lowest cost. Some vendors publish usage rates while others quote a configured package. Compare fee definitions and responsibility boundaries before applying a spreadsheet to either model.

If you mainly want a ready-to-operate bundle, read best turnkey telehealth platforms. Turnkey scope and white-label branding overlap, but they answer different buying questions: who performs the work versus whose brand the patient sees.

What changes when you already have patients?

For an existing brand, make migration part of the initial shortlist rather than a discussion after signing. Request authorized sample exports, identify active treatment and upcoming renewals, and validate matching between clinical and commercial records. A demographic import does not prove continuity for an established patient.

Use the patient migration checklist to define the test cases. Clinical follow-up, lab results, subscriptions and payment credentials each require a plan. Keep the responsible clinical team identified throughout the transition and reconcile billing before the entire population is moved.

What should happen before the final selection?

Reduce the shortlist to proposals that meet the intended clinical and operating requirements. Record unanswered questions and require scope-specific responses before comparing final economics. Use the resource library for additional definitions and checklists, and the white-label guide to clarify ambiguous terms. The final choice should rest on the operation you can actually run, the responsibilities you understand and the patient journey you have tested.

What else should you know?